A study to assess zibotentan pharmacokinetics in participants with moderate hepatic and moderate renal impairment

Trial Identifier:	D4326C00001
Sponsor:	AstraZeneca
NCTID::	NCT05112419
Start Date:	November 2021
Primary Completion Date:	December 2021
Study Completion Date:	December 2021
Condition:	Liver, Pancreas & Gallbladder - Other; Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Bulgarian Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BG	Sofia, BG, 1612

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.